Mimedx (MDXG) EBT Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,211.00 |
| Dec 31, 2025 | 4,413.00 |
| Sep 30, 2025 | 5,023.00 |
| Jun 30, 2025 | 2,892.00 |
| Mar 31, 2025 | 3,588.00 |
| Dec 31, 2024 | 2,161.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 5,208.00 |
| Mar 31, 2024 | 3,335.00 |
| Dec 31, 2023 | 2,545.00 |
| Sep 30, 2023 | 1,100.00 |
| Jun 30, 2023 | 942.00 |
| Mar 31, 2023 | -628.00 |
| Dec 31, 2022 | -827.00 |
| Sep 30, 2022 | -2,793.00 |
| Jun 30, 2022 | -2,493.00 |
| Mar 31, 2022 | -2,648.00 |
| Dec 31, 2021 | 1,296.00 |
| Sep 30, 2021 | -1,040.00 |
| Jun 30, 2021 | -863.00 |
| Mar 31, 2021 | -1,652.00 |
| Dec 31, 2020 | -4,050.00 |
| Sep 30, 2020 | -4,382.00 |
| Jun 30, 2020 | -2,811.00 |
| Mar 31, 2020 | -3,650.00 |
| Dec 31, 2019 | -2,123.00 |
| Sep 30, 2019 | 248.00 |
| Jun 30, 2019 | -2,389.00 |
| Mar 31, 2019 | -1,522.00 |
| Dec 31, 2018 | -151.00 |
| Sep 30, 2018 | 216.00 |
| Jun 30, 2018 | 748.00 |
| Mar 31, 2018 | 1,723.00 |
| Dec 31, 2017 | 3,680.00 |
| Sep 30, 2017 | 6,861.00 |
| Jun 30, 2017 | 2,401.00 |
| Mar 31, 2017 | 3,829.00 |
| Dec 31, 2016 | 8,501.00 |
| Sep 30, 2016 | 8,921.00 |
| Jun 30, 2016 | 13,577.00 |
| Mar 31, 2016 | 32,345.00 |